Device Trial Radar · NCT06230393
An Extension Trial for Patients With Open-Angle Glaucoma Who Participated in the DF6-CL-20-01 Protocol.
Last checked: Nov 19, 2026Latest source record: Mar 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
17
Actual
Start
Jun 1, 2024
Primary completion
Dec 4, 2025
Study completion Dec 4, 2025
Sponsor
- Lead sponsor
- New World Medical, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jan 30, 2024
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate long term safety and effectiveness of the STREAMLINE® SURGICAL SYSTEM
Conditions
- Open Angle Glaucoma
- Intraocular Pressure
Interventions
STREAMLINE® SURGICAL SYSTEMDevice
STREAMLINE® SURGICAL SYSTEM
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in IOPTime frame: 24months; 36 months; 48months, 60 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Clinica 20/20
San José, Costa Rica
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.